Nearly 600,000 bottles of a trusted blood pressure pill were suddenly pulled from shelves across the country, sending quiet shockwaves through medicine cabinets everywhere. Patients who relied on their daily dose of Ramipril had no warning that a contamination concern tied to an overseas supplier would trigger a nationwide recall. The FDA labeled it a Class II recall, meaning the health risk is considered temporary or medically reversible, but,
No illnesses have been reported so far, yet the thought of a cancer-linked impurity has left many wondering how closely global drug suppliers are really monitored. Ramipril remains essential for controlling hypertension and preventing heart attacks and strokes, and officials stress patients should not stop taking it without medical guidance. Still, as people rush to check batch numbers and call their pharmacies, a bigger question about pharmaceutical oversight quietly lingers therefore,